-transparent.png){kind=logo}
Nephrotoxicities of arbekacin (ABK) and/or vancomycin (VCM) were examined by administrating rats intravenously with single doses or 10 times repeated daily doses. ABK was found less toxic to kidney than VCM, and the toxicity was strengthened by combined treatment with VCM and ABK. Fosfomycin decreased the nephrotoxicity when added to the single or combined treatment with ABK and VCM.
Related Publications
T Niizato, and
M Ohnishi, and
S Nishiyama, and
H Asaoka, and
A Saito
February 2003,
The Japanese journal of antibiotics,
T Niizato, and
M Ohnishi, and
S Nishiyama, and
H Asaoka, and
A Saito
October 1986,
Arzneimittel-Forschung,
T Niizato, and
M Ohnishi, and
S Nishiyama, and
H Asaoka, and
A Saito
January 1990,
Antimicrobial agents and chemotherapy,
T Niizato, and
M Ohnishi, and
S Nishiyama, and
H Asaoka, and
A Saito
July 2012,
Human & experimental toxicology,
T Niizato, and
M Ohnishi, and
S Nishiyama, and
H Asaoka, and
A Saito
January 2024,
PloS one,
T Niizato, and
M Ohnishi, and
S Nishiyama, and
H Asaoka, and
A Saito
April 2004,
Antimicrobial agents and chemotherapy,
T Niizato, and
M Ohnishi, and
S Nishiyama, and
H Asaoka, and
A Saito
July 2012,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
T Niizato, and
M Ohnishi, and
S Nishiyama, and
H Asaoka, and
A Saito
March 1995,
The Japanese journal of antibiotics,
T Niizato, and
M Ohnishi, and
S Nishiyama, and
H Asaoka, and
A Saito
March 1989,
Lancet (London, England),
T Niizato, and
M Ohnishi, and
S Nishiyama, and
H Asaoka, and
A Saito
December 2014,
Journal of pharmacy practice,
